COMMUNIQUÉS West-GlobeNewswire

PotNetwork Holdings' Diamond CBD, Inc. Puts Smack Down on Bullying Through Alliance with Former MMA Pro,Carlos Flores, and the Bully Rehab Awareness Gym
23/05/2018
Company Moves to Break Into MMA, the Fastest-Growing Sport on the Planet FT. LAUDERDALE, Fla., May 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) is pleased to announce that [...]
Capital Senior Living Corporation to Present at the Jefferies 2018 Healthcare Conference on Tuesday, June 5, 2018
23/05/2018
DALLAS, May 23, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, today announced that management will make a [...]
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Enter into Ex-U.S. Licensing Agreement to Commercialize KORSUVA™ Injection in Dialysis Patients with Pruritus
23/05/2018
Cara receives upfront payment of $50 million in cash and an equity investment of $20 million Cara eligible for up to $470 million in regulatory and commercial milestones VFMCRP to commercialize KORSUVA injection [...]
Solon Eiendom ASA : Annual general Meeting held 23 May 2018
23/05/2018
Oslo, 23 May 2018: Solon Eiendom ASA (OSE: SOLON) held annual general meeting at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 23 May 2018. The general meeting resolved the board's proposal of a [...]
Lundbeck increases its share capital by 41,946 shares (0.0211 % of outstanding shares) as a result of exercise of employee warrants
23/05/2018
Valby, Denmark, 23 May 2018 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 209,730 as a consequence of the exercise of employee warrants. The increase is effected [...]
Acarix AB recruits Per Persson as Chief Commercial Officer
23/05/2018
Press release Malmö, May 23, 2018 Acarix AB recruits Per Persson as Chief Commercial Officer Acarix AB (publ) ("Acarix"), today announced the recruitment of Per Persson as new Chief Commercial Officer to accelerate the [...]
New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication
23/05/2018
Late-Breaking SPYRAL HTN-ON MED Study at EuroPCR Indicates RDN Lowers Blood Pressure in Hypertensive Patients in Presence of BP Medication DUBLIN and PARIS - May 23, 2018 - Medtronic plc (NYSE: MDT ) today announced [...]
Navamedic ASA: Invitation to presentation of first quarter 2018
23/05/2018
Navamedic ASA invites you to a presentation of the first quarter 2018 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Wednesday 30 May. The presentation will start at 08.00 The [...]
Allscripts Sunrise™ powers The Dudley Group NHS Foundation Trust to transform delivery of care
23/05/2018
One of the country’s largest teaching hospitals leads the way in connecting the health economy in U.K. and provides tools to increase efficiency in an era of ever greater demand DUDLEY, United Kingdom, May 23, 2018 ( [...]
FIT Biotech Oy: FIT Biotech files two international patent applications
23/05/2018
FIT Biotech Oy Company release 23.5.2018 at 9.30 EET FIT Biotech files two international patent applications FIT Biotech Oy ("company", FITBIO:FN Finland) has filed two international patent applications. These [...]
Acarix Interim Report, January - March 2018 : CADScor®System launched in key markets
23/05/2018
Interim Report, January - March 2018 Malmö, May 23, 2018 CADScor®System launched in key markets "Acarix introduced the CADScor®System on the German, Swedish and Danish markets 11 months ago, in June 2017. The [...]
ThromboGenics to present a preclinical overview of its two most advanced diabetic eye disease clinical candidates, THR-317 and THR-149, at EASDec 2018
23/05/2018
Press release Leuven, Belgium, 23 May 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that its CSO Jean Feyen, PhD, and Senior [...]
Shire plc : Rule 2.9 Announcement
23/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 23 May 2018 Shire [...]
Verona Pharma Files Shelf Registration Statement with SEC
23/05/2018
Shareholders’ Circular and Notice of General Meeting LONDON, May 23, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company [...]
Photocure ASA: Results for the first quarter of 2018
23/05/2018
Oslo, Norway, 23 May 2018: Photocure ASA (OSE: PHO ), today reported a revenue growth of 36% in local currency for the important U.S. market in the first quarter of 2018, contributing to Hexvix/Cysview revenues of NOK [...]
VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS
23/05/2018
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) to develop and commercialise CR845/difelikefalin injection worldwide except in the US, Japan and South Korea for the treatment of chronic kidney disease-associated [...]
MyoKardia Announces Pricing of Public Offering of Common Stock
23/05/2018
SOUTH SAN FRANCISCO, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
Coherus Prices Public Offering of Common Stock
23/05/2018
REDWOOD CITY, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ) today announced the pricing of its underwritten public offering of 5,172,413 shares of its common stock at a price to the [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
22/05/2018
MARKHAM, Ontario, May 22, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]

Pages